2008
DOI: 10.1128/jvi.01371-08
|View full text |Cite
|
Sign up to set email alerts
|

Accelerated Prion Replication in, but Prolonged Survival Times of, Prion-Infected CXCR3−/−Mice

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

3
28
0

Year Published

2010
2010
2018
2018

Publication Types

Select...
5
2
1

Relationship

0
8

Authors

Journals

citations
Cited by 41 publications
(31 citation statements)
references
References 76 publications
3
28
0
Order By: Relevance
“…The involvement of CXCL12/ CXCR4 signaling in hMSCs migration is consistent with findings in hypoglossal nerve injury (24), ischemic (63), and glioma (11) (6,45). In prion diseases, impairment of microglial migration, associated with the increased accumulation of PrP Sc but prolongation of survival, has been reported in CXCR3 gene deficient mice infected with prions (47). Microglial recruitment in retina after intraocular injection of homogenates from prion-infected neuroblastoma cells was inhibited by CCR5 antagonist, suggesting the involvement of CCR5 in microglial response to prion infection (34), although ablation of CCR5 gene did not influence the incubation period after prion infection (55).…”
Section: Discussionsupporting
confidence: 85%
“…The involvement of CXCL12/ CXCR4 signaling in hMSCs migration is consistent with findings in hypoglossal nerve injury (24), ischemic (63), and glioma (11) (6,45). In prion diseases, impairment of microglial migration, associated with the increased accumulation of PrP Sc but prolongation of survival, has been reported in CXCR3 gene deficient mice infected with prions (47). Microglial recruitment in retina after intraocular injection of homogenates from prion-infected neuroblastoma cells was inhibited by CCR5 antagonist, suggesting the involvement of CCR5 in microglial response to prion infection (34), although ablation of CCR5 gene did not influence the incubation period after prion infection (55).…”
Section: Discussionsupporting
confidence: 85%
“…Our study suggests that blocking CXCR3 is beneficial and warrants further investigation of this pathway in TON as well as evaluation of the effects of a number of CXCR3 antagonists, which are in clinical development for treating inflammatory diseases in human subjects. This study, together with previous findings that deleting CXCR3 prevents retinal neuronal cell death after an acute increase in intraocular pressure, 21 prolongs survival times after prion infection, 57 reduces NMDA-induced neuronal cell death in brain, 58 and attenuates plaque formation and behavioral deficits in Alzheimer disease, 59 highlights a role of CXCR3 in neurodegenerative diseases. The CXCL10/CXCR3 axis plays a critical role in inflammation by recruiting activated T lymphocytes, monocytes, and macrophages.…”
Section: Discussionsupporting
confidence: 80%
“…Resident glial cells of the brain functionally express CXCR3, but the impact of glial CXCR3 expression on AD progression is not yet clarified (23-26). ies examining the role of CXCR3 in other models of neurodegeneration, showing the absence of CXCR3 is associated with attenuated microglial activation, reduced expression of inflammatory factors, and constrained microglial recruitment (25,26,55,58). Concerning the mechanisms leading to diminished Aβ load in CXCR3-deficient APP/PS1 mice, based on the in vivo phagocysotis data, we hypothesized that CXCR3-deficient microglia are more capable of phagocytosing Aβ in the APP/PS1 model.…”
Section: Discussionmentioning
confidence: 99%
“…CXCR3 is a well-known modulator of microglial function (23,25,26,55). To elucidate the impact of Cxcr3 -/-on the morphological phenotype of microglia in APP/ PS1 mice, we characterized periplaque accumulation and activation by morphological criteria.…”
Section: Decreased Aβ Deposition and Aβ Level In Cxcr3-deficient App/ps1mentioning
confidence: 99%